Filing Flows › Iradimed (IRMD) › Q3 2026
Iradimed (IRMD) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 30, 2026
Iradimed (IRMD) reported revenue of $24.2M for the third quarter 2026 (Q3 2026), +14% from a year earlier and +18% from the quarter before. Operating margin was 33.6%, net earnings $6.5M (26.9% of revenue).
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.2M | +18% | +14% |
| Gross profit | $18.5M | +22% | +12% |
| Operating profit | $8.1M | +27% | +19% |
| Net earnings | $6.5M | +25% | +17% |
| Operating cash flow | $7.0M | +18% | +0.2% |
| Free cash flow | $6.8M | — | +19% |
What changed
Revenue was $24.2M in Q3 2026, up 14% year over year and up 18% from the previous quarter. MRI Compatible IV Infusion Pumps was the largest line at 36% of revenue. MRI Compatible Patient Vital Signs Monitoring Systems added $1.1M year over year (up 17%), 38% of the total change.
Gross margin was 76.3%, down 1.5 points from Q3 2025. Operating profit was $8.1M, a 33.6% margin (up 1.4 points year over year). Of the extra revenue versus Q3 2025, 44% reached operating profit, above the 32% margin then. Operating expenses grew 7% against revenue growth of 14%. The fastest-growing cost line was Research & development (+30%). Net earnings were $6.5M, up 17% year over year. The effective tax rate was 24.9%.
Operating cash flow was $7.0M (roughly flat year over year), 108% of net earnings. Non-cash charges added back $412K of depreciation and amortization and $777K of share-based compensation. Working capital and other items used $698K. After capital Expenditures ($212K), free cash flow as the company reports it was $6.8M.
Questions
What was Iradimed's revenue in the third quarter 2026?
Iradimed (IRMD) reported revenue of $24.2M for the third quarter 2026 (Q3 2026), +14% from a year earlier and +18% from the quarter before.
Was Iradimed profitable in the third quarter 2026?
Operating profit was $8.1M (33.6% of revenue) and net earnings $6.5M.
Source: Iradimed 10-Q on SEC EDGAR.